IFP Advisors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $273K | Buy |
2,172
+88
| +4% | +$11.1K | 0.01% | 1109 |
|
|
2025
Q1 | $230K | Buy |
2,084
+64
| +3% | +$7.08K | 0.01% | 1110 |
|
|
2024
Q4 | $276K | Buy |
2,020
+137
| +7% | +$18.7K | 0.01% | 982 |
|
|
2024
Q3 | $217K | Sell |
1,883
-184
| -9% | -$21.2K | 0.01% | 1050 |
|
|
2024
Q2 | $285K | Sell |
2,067
-440
| -18% | -$60.6K | 0.01% | 862 |
|
|
2024
Q1 | $346K | Buy |
2,507
+455
| +22% | +$62.8K | 0.02% | 741 |
|
|
2023
Q4 | $270K | Buy |
2,052
+241
| +13% | +$31.8K | 0.01% | 826 |
|
|
2023
Q3 | $204K | Buy |
1,811
+16
| +0.9% | +$1.8K | 0.01% | 953 |
|
|
2023
Q2 | $169K | Sell |
1,795
-62
| -3% | -$5.85K | 0.01% | 1105 |
|
|
2023
Q1 | $183K | Sell |
1,857
-89
| -5% | -$8.77K | 0.01% | 979 |
|
|
2022
Q4 | $196K | Sell |
1,946
-339
| -15% | -$34.1K | 0.01% | 1364 |
|
|
2022
Q3 | $229K | Buy |
2,285
+567
| +33% | +$56.8K | 0.01% | 1333 |
|
|
2022
Q2 | $170K | Hold |
1,718
| – | – | 0.01% | 1370 |
|
|
2022
Q1 | $170K | Buy |
1,718
+235
| +16% | +$23.3K | 0.01% | 1370 |
|
|
2021
Q4 | $128K | Buy |
1,483
+12
| +0.8% | +$1.04K | ﹤0.01% | 1145 |
|
|
2021
Q3 | $141K | Sell |
1,471
-43
| -3% | -$4.12K | ﹤0.01% | 1096 |
|
|
2021
Q2 | $147K | Sell |
1,514
-111
| -7% | -$10.8K | ﹤0.01% | 1059 |
|
|
2021
Q1 | $158K | Buy |
1,625
+195
| +14% | +$19K | ﹤0.01% | 946 |
|
|
2020
Q4 | $137K | Buy |
1,430
+420
| +42% | +$40.2K | 0.01% | 978 |
|
|
2020
Q3 | $96K | Buy |
1,010
+890
| +742% | +$84.6K | 0.01% | 1017 |
|
|
2020
Q2 | $15K | Buy |
120
+10
| +9% | +$1.25K | ﹤0.01% | 1666 |
|
|
2020
Q1 | $10K | Sell |
110
-23
| -17% | -$2.09K | ﹤0.01% | 1763 |
|
|
2019
Q4 | $14K | Sell |
133
-77
| -37% | -$8.11K | ﹤0.01% | 1774 |
|
|
2019
Q3 | $19K | Buy |
+210
| New | +$19K | ﹤0.01% | 1786 |
|
|
2019
Q1 | $10K | Sell |
110
-207
| -65% | -$18.8K | ﹤0.01% | 1605 |
|
|
2018
Q4 | $22K | Sell |
317
-112
| -26% | -$7.77K | ﹤0.01% | 2054 |
|
|
2018
Q3 | $53K | Buy |
429
+112
| +35% | +$13.8K | ﹤0.01% | 1856 |
|
|
2018
Q2 | $31K | Buy |
317
+107
| +51% | +$10.5K | ﹤0.01% | 2184 |
|
|
2018
Q1 | $16K | Hold |
210
| – | – | ﹤0.01% | 2529 |
|
|
2017
Q4 | $16K | Buy |
210
+110
| +110% | +$8.38K | ﹤0.01% | 2527 |
|
|
2017
Q3 | $6K | Hold |
100
| – | – | ﹤0.01% | 3275 |
|
|
2017
Q2 | $5K | Hold |
100
| – | – | ﹤0.01% | 3381 |
|
|
2017
Q1 | $4K | Hold |
100
| – | – | ﹤0.01% | 3390 |
|
|
2016
Q4 | $4K | Sell |
100
-8
| -7% | -$320 | ﹤0.01% | 3383 |
|
|
2016
Q3 | $5K | Buy |
108
+8
| +8% | +$370 | ﹤0.01% | 3228 |
|
|
2016
Q2 | $5K | Sell |
100
-10
| -9% | -$500 | ﹤0.01% | 3143 |
|
|
2016
Q1 | $10K | Sell |
110
-29
| -21% | -$2.64K | ﹤0.01% | 1605 |
|
|
2015
Q4 | $8K | Buy |
+139
| New | +$8K | ﹤0.01% | 2683 |
|